Fifth Third Bancorp’s Amicus Therapeutics FOLD Stock Holding History

Fifth Third Bancorp’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$37.5K	Buy	+2,593	New	+$37.2K	﹤0.01%	3300
2025 Q4	–	Sell	-100	Closed	-$788	–	2668
2025 Q3	$788	Buy	+100	New	+$712	﹤0.01%	2560
2021 Q4	–	Sell	-213	Closed	-$2K	–	2709
2021 Q3	$2K	Hold	213	–	–	﹤0.01%	2448
2021 Q2	$2K	Sell	213 -573	-73%	-$5.59K	﹤0.01%	2334
2021 Q1	$8K	Sell	786 -196	-20%	-$3.03K	﹤0.01%	2069
2020 Q4	$23K	Sell	982 -8,419	-90%	-$172K	﹤0.01%	1665
2020 Q3	$133K	Buy	+9,401	New	+$137K	﹤0.01%	1018
2019 Q4	–	Sell	-289	Closed	-$2K	–	2245
2019 Q3	$2K	Buy	+289	New	+$3.14K	﹤0.01%	2051
2019 Q1	–	Sell	-965	Closed	-$9K	–	2200
2018 Q4	$9K	Buy	+965	New	+$10.6K	﹤0.01%	1803

Other funds holding FOLD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Fifth Third Bancorp's FOLD Position: Q1 2026 in Review

Fifth Third Bancorp opened a new position in Amicus Therapeutics (FOLD) in Q1 2026: 2,593 shares worth $37.5K. The stake represents ﹤0.01% of the portfolio and ranks #3300 among its holdings. This is a return to the name: Fifth Third Bancorp previously reported a position in FOLD as recently as Q3 2025.

Fifth Third Bancorp first reported a position in FOLD in Q4 2018 and has held it in 9 quarters since. The position peaked at $133K in Q3 2020. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

Fifth Third Bancorp held 2,593 shares of Amicus Therapeutics worth $37.5K as of Q1 2026.
Amicus Therapeutics was a new Fifth Third Bancorp position in Q1 2026.
Amicus Therapeutics made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q1 2026, its #3300 holding.
Fifth Third Bancorp first reported a position in Amicus Therapeutics in Q4 2018 and has held it in 9 quarters since.
Fifth Third Bancorp's Amicus Therapeutics position peaked at $133K in Q3 2020.
298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.